دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
New Therapeutic Approaches Involving Psychopharmacology, Digital Technology, and fMRI Neurofeedback
Ned H. Kalin, M.D.
doi : 10.1176/appi.ajp.20220866
Volume 179, Issue 12
Neurofeedback for ADHD: Time to Call It Quits?
James J. McGough, M.D., M.S.
An Innovative Approach to Extending the Antidepressant Effects of Intravenous Ketamine in Major Depression
Alan F. Schatzberg, M.D.
A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability
Gregory Barber, M.D., Charles B. Nemeroff, M.D., Ph.D., Steven Siegel, M.D., Ph.D.
Technology and Mental Health: State of the Art for Assessment and Treatment
Philip D. Harvey, Ph.D., Colin A. Depp, Ph.D., Albert A. Rizzo, Ph.D., Gregory P. Strauss, Ph.D., David Spelber, M.D., Linda L. Carpenter, M.D., Ned H. Kalin, M.D., John H. Krystal, M.D., William M. McDonald, M.D., Charles B. Nemeroff, M.D., Ph.D., Carolyn I. Rodriguez, M.D., Ph.D., Alik S. Widge, M.D., Ph.D., John Torous, M.D.
Targeted Oral Naltrexone for Mild to Moderate Alcohol Use Disorder Among Sexual and Gender Minority Men: A Randomized Trial
Glenn-Milo Santos, Ph.D., M.P.H., Janet Ikeda, M.A., Phillip Coffin, M.D., M.I.A., John Walker, N.P., Tim Matheson, Ph.D., Arsheen Ali, B.A., Matthew McLaughlin, A.B., Jennifer Jain, Ph.D., M.P.H., Justine Arenander, M.S.W., Eric Vittinghoff, Ph.D., Steven Batki, M.D.
Naltrexone-Bupropion and Behavior Therapy, Alone and Combined, for Binge-Eating Disorder: Randomized Double-Blind Placebo-Controlled Trial
Carlos M. Grilo, Ph.D., Janet A. Lydecker, Ph.D., Sarah K. Fineberg, M.D., Ph.D., Jorge O. Moreno, M.D., Valentina Ivezaj, Ph.D., Ralitza Gueorguieva, Ph.D.
Effectiveness of Antipsychotic Use for Reducing Risk of Work Disability: Results From a Within-Subject Analysis of a Swedish National Cohort of 21,551 Patients With First-Episode Nonaffective Psychosis
Marco Solmi, M.D., Ph.D., Heidi Taipale, Ph.D., Minna Holm, Ph.D., Antti Tanskanen, Ph.D., Ellenor Mittendorfer-Rutz, Ph.D., Christoph U. Correll, M.D., Ph.D., Jari Tiihonen, M.D., Ph.D.
Double-Blind, Sham-Controlled Randomized Trial Testing the Efficacy of fMRI Neurofeedback on Clinical and Cognitive Measures in Children With ADHD
Sheut-Ling Lam, Ph.D., Marion Criaud, Ph.D., Steve Lukito, Ph.D., Samuel J. Westwood, Ph.D., Deborah Agbedjro, Ph.D., Olivia S. Kowalczyk, Ph.D., Sarah Curran, M.D., Ph.D., Nadia Barret, M.D., Chris Abbott, M.D., Holan Liang, M.A, M.D., Emily Simonoff, M.D., Gareth J. Barker, Ph.D., Vincent Giampietro, Ph.D., Katya Rubia, Ph.D.
A Novel, Brief, Fully Automated Intervention to Extend the Antidepressant Effect of a Single Ketamine Infusion: A Randomized Clinical Trial
Rebecca B. Price, Ph.D., Crystal Spotts, M.Ed., Benjamin Panny, B.S., Angela Griffo, B.S., Michelle Degutis, M.S., Nicolas Cruz, M.Ed., Elizabeth Bell, B.S., Kevin Do-Nguyen, B.S., Meredith L. Wallace, Ph.D., Sanjay J. Mathew, M.D., Robert H. Howland, M.D.
